A -- Inositol Signaling Molecules

The Uniformed Services University is initiating a sole source contract negotiation with Inologic, Inc. to conduct specialized research on Inositol Signaling Molecules. This project aims to develop a small molecule drug based on inositol polyphosphates that can prevent or reverse damage caused by ionizing radiation. The rationale behind the research is grounded in the natural cellular mechanisms that repair radiation-induced damage via intracellular signaling pathways, where inositol signaling molecules play a critical regulatory role. The expected outcome is the creation of an analog of these molecules that could specifically enhance DNA double strand break repair and bolster cell recovery processes, acting as a radioprotective agent to safeguard cells, particularly bone marrow progenitor cells, from radiation damage. The contract will focus on identifying lead candidates among these inositol signaling molecule analogs with potential to advance into further development and testing as radiation countermeasures. The work falls under the authority of 10 U.S.C. 2304(c)(1) and is being managed by the Office of the Department of Defense at the Uniformed Services University in Bethesda, Maryland. Michelle Creenan serves as the contracting specialist for this effort, which was posted as a presolicitation to encourage focused research on mitigating the harmful effects of radiation exposure through innovative biochemical approaches.